Cyclobenzaprine Hydrochloride 30mg ER Tablet in PCD pharma franchise in Hyderabad

Cyclobenzaprine Hydrochloride 30mg ER Tablet in pharmaceutical manufacturing company in Mumbai

Cyclobenzaprine Hydrochloride 30mg ER Tablet in muscle relaxant pharma franchise in Pune

Cyclobenzaprine Hydrochloride 30mg ER Tablet in pharma suppliers in Delhi

Cyclobenzaprine Hydrochloride 30mg ER Tablet in pharma export companies in Kolkata
Benzaflit 30 Tablet in pain & muscle spasm pharma franchise opportunities in Bengaluru

Home/Products /cyclobenzaprine-hydrochloride-i-point-p-30mg-er-tablets

Benzaflit 30 Tablet

Composition : Cyclobenzaprine Hydrochloride I.P. 30mg (ER Tablets)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹300/-

Contact For Business Query

Benzaflit 30 Tablet contains Cyclobenzaprine Hydrochloride 30mg in an extended-release form. Cyclobenzaprine is a centrally acting skeletal muscle relaxant used to relieve muscle spasms and associated discomfort. It works by reducing somatic motor activity through central nervous system pathways, without directly affecting the muscles. The extended-release formulation allows for once-daily dosing, providing consistent relief from muscle spasm-related pain and improving patient compliance.

Read More

About the Product

Benzaflit 30 Tablet contains Cyclobenzaprine Hydrochloride 30mg in an extended-release form. Cyclobenzaprine is a centrally acting skeletal muscle relaxant used to relieve muscle spasms and associated discomfort. It works by reducing somatic motor activity through central nervous system pathways, without directly affecting the muscles. The extended-release formulation allows for once-daily dosing, providing consistent relief from muscle spasm-related pain and improving patient compliance.

Benzaflit 30 Tablet is usually well tolerated, though some patients may experience drowsiness, dry mouth, dizziness, or fatigue. In rare cases, it may cause blurred vision, confusion, or difficulty in urination. These effects are more likely in elderly patients or those with pre-existing conditions. Seek medical attention if side effects persist or worsen.

This tablet is indicated for the short-term treatment of muscle spasms associated with acute musculoskeletal conditions such as strains, sprains, and injuries. It is generally used in combination with rest and physical therapy to improve functional recovery and alleviate pain and stiffness.

This medication should be used only under the supervision of a healthcare professional. It is not intended for long-term use and is typically recommended for a maximum of 2–3 weeks. Avoid combining it with alcohol or sedatives. It may impair alertness, so caution is advised while driving or operating machinery. Do not use it if you are currently taking or have recently stopped taking monoamine oxidase inhibitors (MAOIs).

Store in a cool, dry place below 25°C, away from moisture and direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation

@2024 | copy rights by Cafoli